Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.54% |
| 2 | Technology | 19.7% |
| 3 | Financials | 7.47% |
| 4 | Consumer Discretionary | 6.7% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1201
The Ensign Group
ENSG
$10B
| $22.3M | 0.01% |
127,998
-8,242
| -6% | -$1.48M |
2013 Q2
50 quarters
|
|
1202
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.41B
| $22.2M | 0.01% |
676,367
-466,881
| -41% | -$15.3M |
2023 Q4
8 quarters
|
|
1203
Sprouts Farmers Market
SFM
$6.01B
| $22.2M | 0.01% |
278,372
-308,752
| -53% | -$27.7M |
2013 Q3
49 quarters
|
|
1204
BILL Holdings
BILL
$3.72B
| $22.2M | 0.01% |
406,503
-11,152
| -3% | -$573K |
2022 Q1
15 quarters
|
|
1205
PUT
Bath & Body Works
BBWI
$3.24B
| $22.1M | 0.01% |
1,103,000
-2,819,700
| -72% | -$62.3M |
2024 Q4
4 quarters
|
|
1206
Huntsman Corp
HUN
$1.5B
| $22.1M | 0.01% |
2,208,925
+1,573,730
| +248% | +$14.4M |
2013 Q2
50 quarters
|
|
1207
TransUnion
TRU
$12.2B
| $22.1M | 0.01% |
257,449
-76,547
| -23% | -$6.29M |
2015 Q2
42 quarters
|
|
1208
CALL
Macy's
M
$5.94B
| $22.1M | 0.01% |
1,000,000
-500,000
| -33% | -$10.2M |
2023 Q4
8 quarters
|
|
|
PSKY
1209
Paramount Skydance Corp
PSKY
$10.7B
| $21.9M | 0.01% |
1,632,906
-12,013,798
| -88% | -$188M |
2025 Q3
1 quarter
|
|
1210
Cytokinetics
CYTK
$9.12B
| $21.8M | 0.01% |
343,458
-54,617
| -14% | -$3.4M |
2013 Q3
49 quarters
|
|
1211
CALL
J.M. Smucker
SJM
$12.5B
| $21.8M | 0.01% |
222,600
| – | – |
2025 Q2
2 quarters
|
|
|
GAP
1212
PUT
The Gap Inc
GAP
$7.91B
| $21.8M | 0.01% |
850,100
-122,500
| -13% | -$2.97M |
2024 Q3
5 quarters
|
|
1213
LivaNova
LIVN
$4.14B
| $21.7M | 0.01% |
353,228
-31,573
| -8% | -$1.8M |
2015 Q4
40 quarters
|
|
1214
Credicorp
BAP
$29.6B
| $21.7M | 0.01% |
75,699
-89,562
| -54% | -$23.7M |
2013 Q4
48 quarters
|
|
1215
CALL
Apollo Global Management
APO
$67.3B
| $21.7M | 0.01% |
150,000
-9,000
| -6% | -$1.2M |
2024 Q2
6 quarters
|
|
1216
American Homes 4 Rent
AMH
$10.9B
| $21.7M | 0.01% |
675,906
+172,113
| +34% | +$5.52M |
2013 Q3
49 quarters
|
|
1217
PUT
Jefferies Financial Group
JEF
$10.6B
| $21.7M | 0.01% |
+350,000
| New | +$20.1M |
2025 Q4
0 quarters
|
|
1218
Dycom Industries
DY
$8.26B
| $21.6M | 0.01% |
64,010
+7,908
| +14% | +$2.49M |
2013 Q2
50 quarters
|
|
1219
CALL
Papa John's
PZZA
$640M
| $21.6M | 0.01% |
+561,800
| New | +$24.8M |
2025 Q4
0 quarters
|
|
1220
PUT
ResMed
RMD
$30.8B
| $21.6M | 0.01% |
89,500
+82,500
| +1,179% | +$21.1M |
2024 Q3
5 quarters
|
|
1221
XPeng
XPEV
$8.86B
| $21.5M | 0.01% |
1,060,869
+840,874
| +382% | +$18.2M |
2022 Q1
15 quarters
|
|
1222
Check Point Software Technologies
CHKP
$13.3B
| $21.5M | 0.01% |
115,880
+39,967
| +53% | +$7.73M |
2013 Q4
48 quarters
|
|
1223
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.42B
| $21.5M | 0.01% |
592,205
+18,337
| +3% | +$665K |
2020 Q2
22 quarters
|
|
1224
iPath Series B S&P 500 VIX Mid-Term Futures ETN
VXZ
$27.8M
| $21.4M | 0.01% |
400,526
| – | – |
2021 Q1
19 quarters
|
|
1225
Houlihan Lokey
HLI
$8.83B
| $21.4M | 0.01% |
122,900
-106,175
| -46% | -$19.5M |
2016 Q3
37 quarters
|
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $23.5B in Q4 2025, closing 641 positions and reducing 1,714 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.